AI is transforming the pharmaceutical industry

The astonishing speed of digital disruption today calls for new and emerging technologies that are capable of long-term value creation. Poised at this intersection of digital revolution, business and accelerated scientific discovery, leaders across verticals have formulated a vision to begin their transformative journey. Though laggards at the beginning, the pharmaceutical industry has eventually started taking advantage of new-age technologies in areas from clinical trials to manufacturing. AI is already known to be speeding and improving the drug discovery process, owing to its capability of sifting through and making sense of heaps of scientific data related to research and development. It has also started making inroads into newer and more diverse areas like drug manufacturing and supply chains, which are the least explored in the Life Sciences space, yet have the capability to offer maximum benefits.